MARC E LIPPMAN, MD
Medical Practice at Edgewater Dr, Miami, FL

License number

Florida 98970

Issued Date

Jun 12, 2007

Effective Date

Jun 12, 2007

Expiration Date

Jan 31, 2019

Professional information

Dr. Marc E Lippman, Miami FL - MD (Doctor of Medicine)

Specialties:

Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism, Medical Oncology, Oncology

Address:

Sylvester Comp Cnr Ctr Hem/Onco
1475 NW 12Th Ave STE 3300, Miami 33136
(305) 243-6102 (Phone)

Certifications:

Diabetes, Metabolism & Endocrinology, 1975, Internal Medicine, 1987, Medical Oncology, 1977

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

Sylvester Comp Cnr Ctr Hem/Onco
1475 NW 12Th Ave STE 3300, Miami 33136
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109

Education:

Medical School
Yale University
Graduated: 1968
The Johns Hopkins Hospital
Natl Canc Inst
Yale

Assistant Director, Player Development &Amp; International Operations At Miami Marlins

Position:

Assistant Director, Player Development & International Operations at Miami Marlins

Location:

Miami/Fort Lauderdale Area

Industry:

Sports

Work:

Miami Marlins since Nov 2010 - Assistant Director, Player Development & International Operations Florida Marlins May 2007 - Nov 2010 - Assistant, Baseball Operations Florida Marlins Feb 2007 - May 2007 - Intern, Player Development Florida Marlins Mar 2006 - Feb 2007 - Intern, Media Relations Minnesota Twins Jun 2004 - Aug 2004 - Intern

Education:

Washington University in St. Louis 2001 - 2005
Washington University in St. Louis - Olin Business School 2001 - 2005

Marc E Lippman, Ann Arbor MI

Specialties:

Oncologist

Address:

1500 E Medical Center Dr, Ann Arbor, MI 48109
1475 Nw 12Th Ave, Miami, FL 33136

Education:

Yale University, School of Medicine - Doctor of Medicine
Yale New Haven Psychiatric Hospital - Fellowship - Endocrinology
National Institutes of Health-Clinical Center - Fellowship - Oncology (Internal Medicine)
Johns Hopkins Hospital - Residency - Family Medicine

Board certifications:

American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Chairman Department Of Internal Medicine At University Of Miami

Position:

chairman department of internal medicine at University of Miami

Location:

Miami/Fort Lauderdale Area

Industry:

Higher Education

Work:

University of Miami - chairman department of internal medicine

Marc Lippman, Miami FL

Work:

Sylvester Comprehensive Cancer Center
1475 NW 12Th Ave, Miami, FL 33136 Jackson Memorial Hospital
1611 NW 12Th Ave, Miami, FL 33136

Novel Greb1A Monoclonal Antibody

US Patent:

2011012, May 26, 2011

Filed:

Oct 20, 2010

Appl. No.:

12/908348

Inventors:

Marc E. Lippman - Coral Gables FL, US
Harry James Hnatyszyn - Coral Gables FL, US
Mingli Liu - Marietta GA, US
James M. Rae - Dexter MI, US

Assignee:

UNIVERSITY OF MIAMI - Miami FL
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI

International Classification:

A61K 51/00, A61K 39/395, A61K 39/00, C07K 14/00, A61P 35/00, C07K 16/18, C07H 21/04

US Classification:

424 149, 4241741, 4241781, 530350, 5303879, 5303881, 5303891, 5303913, 536 231

Abstract:

The generation and validation of a novel monoclonal GREB1 antibody (GREB1ab). Methods for the prognosis, diagnosis, assessment of disease progression, severity and outcome utilize GREB1 molecules as biomarkers. The GREB1 antibody is also a useful tool for investigations focused on the expression, distribution and function of GREB1 in normal and cancer tissues.